Clinical Trial Update: Evaluating the Efficacy and Safety of Dehypotin® in the Patients With Type 2 Diabetes Mellitus or Cardiovascular Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Dehypotin in patients with Type 2 Diabetes Mellitus and cardiovascular disease was TERMINATED, with hypercholesterolemia lis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Hypercholesterolemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Dehypotin®

Snippet

Sponsor: Nang Kuang Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes Mellitus, Cardiovascular Disease | Phase 4 | Status: TERMINATED